全文获取类型
收费全文 | 20196篇 |
免费 | 1242篇 |
国内免费 | 394篇 |
专业分类
耳鼻咽喉 | 195篇 |
儿科学 | 981篇 |
妇产科学 | 373篇 |
基础医学 | 1529篇 |
口腔科学 | 263篇 |
临床医学 | 1733篇 |
内科学 | 1310篇 |
皮肤病学 | 230篇 |
神经病学 | 714篇 |
特种医学 | 1142篇 |
外国民族医学 | 4篇 |
外科学 | 5117篇 |
综合类 | 2411篇 |
现状与发展 | 3篇 |
预防医学 | 498篇 |
眼科学 | 154篇 |
药学 | 1037篇 |
14篇 | |
中国医学 | 201篇 |
肿瘤学 | 3923篇 |
出版年
2024年 | 38篇 |
2023年 | 284篇 |
2022年 | 588篇 |
2021年 | 716篇 |
2020年 | 655篇 |
2019年 | 569篇 |
2018年 | 613篇 |
2017年 | 534篇 |
2016年 | 634篇 |
2015年 | 678篇 |
2014年 | 1197篇 |
2013年 | 1196篇 |
2012年 | 1042篇 |
2011年 | 1038篇 |
2010年 | 891篇 |
2009年 | 899篇 |
2008年 | 1008篇 |
2007年 | 1013篇 |
2006年 | 950篇 |
2005年 | 780篇 |
2004年 | 689篇 |
2003年 | 597篇 |
2002年 | 538篇 |
2001年 | 461篇 |
2000年 | 450篇 |
1999年 | 357篇 |
1998年 | 367篇 |
1997年 | 316篇 |
1996年 | 293篇 |
1995年 | 257篇 |
1994年 | 263篇 |
1993年 | 168篇 |
1992年 | 171篇 |
1991年 | 169篇 |
1990年 | 141篇 |
1989年 | 121篇 |
1988年 | 131篇 |
1987年 | 101篇 |
1986年 | 102篇 |
1985年 | 121篇 |
1984年 | 107篇 |
1983年 | 60篇 |
1982年 | 88篇 |
1981年 | 98篇 |
1980年 | 83篇 |
1979年 | 77篇 |
1978年 | 62篇 |
1977年 | 46篇 |
1976年 | 32篇 |
1974年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Herbert Radner Yosuf El-Shabrawi Robert H. Eibl Oliver Brüstle Lukas Kenner Paul Kleihues Otmar D. Wiestler 《Acta neuropathologica》1993,86(5):456-465
Introduction into fetal rat brain cells of a replication-defective retroviral vector harboring v-Ha-ras and v-gag-myc rapidly causes the induction of highly malignant undifferentiated neuroectodermal tumors following transplantation into the brains of syngeneic hosts [Wiestler, et al. (1992) Cancer Res. 52: 3760–3767]. In the present study, we have investigated the modulating effect of the developmental stage of neural target cells and of the dose of the retroviral vector used in the grafting experiments. Exposure of fetal cells from embryonic day (E)12 or E14 produced a 100% incidence of malignant neuroectodermal tumors which led to the death of recipient animals after a median latency period of 32 days. A 100-fold reduction of the virus dose from 2.062×106 to 2.062×104 focus-forming units/ml resulted in a lower tumor incidence of 25%. Of six neural grafts exposed to v-Ha-ras and v-myc at E16, only one showed evidence of tumorigenesis (low-grade astrocytoma and hemangioma). All other transplants were morphologically normal for observation periods of 26 weeks, indicating a marked loss of transforming activity of ras and myc in more advanced stages of brain development. In retrovirus-exposed donor cells which caused the development of neural tumors in recipient rats, malignant transformation was also evident during culture in vitro, usually after 9–12 days. Oncogene complementation was also studied in the newborn rat brain. After microinjection of the retroviral vector into the brain at postnatal day (P)0, P1 and P3, 5 out of 20 animals (25%) developed a total of seven brain tumors. Histopathologically, three of these neoplasms were malignant neuroectodermal tumors which, in contrast to those induced in fetal brain transplants showed evidence of focal glial and/or neuronal differentiation. In addition, we observed one oligodendroglioma, two hemangiomas and a malignant hemangioendothelioma. These data indicate that neural precursor cells and endothelia of the rat brain represent the major target cells for the complementary action of ras and myc and that the use of target cells from later developmental stages (E16 and postnatal) leads to the induction of both primitive and more differentiated neoplasms.These studies were supported by the Fonds zur Förderung der wissenschaftlichen Forschung in Österreich (Erwin Schrödinger fellowship, JO501-MED), by the Swiss National Science Foundation and by the Cancer League of the Kanton of Zürich 相似文献
32.
Summary Intracavitary application of ultrasound was first performed for diagnostic purposes in 1967; since that time, it has been
more and more widely used. As far as the gastrointestinal tract is concerned, endoscopically controlled ultrasonic probes
provide visualization of the various layers of the intestinal wall. It is therefore possible to describe lesions of the esophagus,
stomach, and the rectum with regard to their nature and depth of infiltration. Furthermore, periesophageal and perigastric
organs can be visualized. It has become evident that endosonography is particularly important for pretherapeutic staging of
tumors of the esophagus, stomach, and rectum. Here prospective comparative studies confirm the superiority of this new diagnostic
procedure when compared to the methods available to date. 相似文献
33.
全膀胱切除回肠膀胱术15年总结(附196例报告) 总被引:16,自引:0,他引:16
目的 评价全膀胱切除治疗膀胱肿瘤的疗效及回肠膀胱术的远期效果。 方法 回顾性分析 1985年 1月至 2 0 0 0年 1月膀胱肿瘤行全膀胱切除回肠膀胱术 196例的临床资料。 结果 膀胱肿瘤累及膀胱颈部或膀胱三角区者 12 6例 (6 4.3 % ) ,浸润性膀胱癌 145例 (74.0 % ) ,移行细胞癌183例 (93.4% )。术后发生近期并发症 19例 (9.7% ) ,远期并发症 10例 (7.4% )。 135例随访 1~ 15年 ,平均 6 .6年 ,5年生存率 6 6 .2 %。 结论 全膀胱切除是浸润性膀胱癌首选治疗方法 ,回肠膀胱术简单易行 ,长期随访显示其并发症少 ,疗效确切 ,仍是一种较为理想的尿流改道方式。 相似文献
34.
全去带乙状结肠原位可控膀胱术25例随访报告 总被引:13,自引:2,他引:11
目的:探讨全去带乙状结肠原位可控膀胱术的临床效果。方法:对25例施行该术式术后患者的可控性、尿动力、血清电解质、肾功能、生活质量等进行随访观察。结果:25例随访2-15个月,平均11.3个月。白天完全自控排尿25例(100%);夜间完全自控排尿24例(96.0%),1例偶有遗尿;贮尿囊容量220-370ml,平均320ml;贮尿囊内压力1.86-3.92kPa,平均2.44kPa。IVU及贮尿囊造影示单侧贮尿囊输尿管反流2例(8.0%),无肾积水;膀胱镜检查2例(8.0%)贮尿囊内出现细沙样结石,1例(4.0%)贮尿囊后尿道吻合口狭窄,经尿道直视内切开术治愈。15例(60.0%)男性患者保留性功能,肾功能正常,1例(4.0%)出现一过性高氯血症。结论:全去带乙状结肠原位可控膀胱术手术成功率高,疗效可靠,患者生活质量高,是一种较理想的尿路分流术,值得推广。 相似文献
35.
We report an 80-year-old Japanese male with four primary malignant tumors: malignant melanoma, prostatic cancer, malignant lymphoma, and renal cell carcinoma, which occurred in that respective order. The combination of malignant melanoma and malignant lymphoma is rare. The patient was treated with BCG after an operation for malignant melanoma. He was also treated with cobalt 60 irradiation after an operation for prostatic cancer. We also discuss other reports of multiple malignant tumors and suggest some possible causes of this patient's primary malignant tumors. 相似文献
36.
目的:重视尿路子宫内膜异位症,探讨其诊断,治疗方法,方法:对3例尿路子宫内膜异位症的临床表现和B超,CT,膀胱镜征象以及治疗方法进行分析。结果:术前明确诊断2例,术中发现1例,术后均病理证实,无复发,痊愈出院,疗效满意。结论:确诊需靠腔镜检查或手术探查,诊断应强调详细地询问病史,治疗方法的选择决定于子宫内膜异位症的部位。 相似文献
37.
膀胱肿瘤2350例临床病理学特点分析 总被引:1,自引:0,他引:1
目的 探讨膀胱肿瘤的发病现状、总体趋势和病理特点.方法 整理1980-2007年2350例膀胱肿瘤病理档案,分为1980-1989、1990-1999和2000-2007年3个时间段.应用SPSS 13.0软件分析3时间段患者性别、年龄及肿瘤组织学类型间的关系.结果 2350例膀胱肿瘤中男1854例,女496例.良性92例,恶性2258例,膀胱恶性肿瘤的发病人数逐年上升.发病高峰年龄从50~69岁推迟到60~79岁.1980-1989、1990-1999和2000-2007年3个时间段中男、女恶性肿瘤病例数分别为524例和113例(4.64:11 00)、589例和164例(3.59:1.00)、675例和193例(3.50:1.00),男性约为女性的3.80倍;3时间段男性发生膀胱尿路上皮癌年龄分别为(57.5±11.7)、(62.6±12.3)、(65.9±11.3)岁,女性分别为(58.7±13.6)、(60.7±12.1)、(65.8±12.0)岁,男女各年龄段分别比较差异有统计学意义(P<0.05).男性发生鳞状细胞癌、尿路上皮癌和腺癌年龄分别为(68.05±9.7)、(59.85±14.1)、(63.4±9.9)岁,差异有统计学意义(P相似文献
38.
目的:探讨头颈部良性神经源性肿瘤在单体素^1H MRS上的表现特点。材料和方法:共收集经单体素。HMRS检查,并经手术病理证实的头颈部神经源性肿瘤14例(神经鞘瘤11例,神经纤维瘤2例,颈动脉体瘤1例)。采用点分析波谱法(PRESS:TE=144ms,14例)和激励回波法(STEAM:TE=30ms,11例)进行。HMRS空间定位,以胆碱和脂质代谢物为标准评价所有肿瘤。波谱图上,胆碱和脂质分别在3.2ppm和0.9—1.4ppm区域识别。结果:采用PRESS后,14例神经源性肿瘤中检测出胆碱代谢物者11例,检出脂质代谢物者6例。胆碱和脂质代谢物同时检出者5例,仅检出胆碱者6例,仅检出脂质者1例,胆碱和脂质均未检出者2例。采用STEAM后,11例肿瘤中检出胆碱代谢物和脂质者分别为3例和8例。结论:头颈部良性神经源性肿瘤的单体素。HMRS表现具有多样性,多数肿瘤以长TEPRESS上胆碱峰的显示为特点,长TEPRESS能较STEAM更好地检出良性神经源性肿瘤内的胆碱代谢物。 相似文献
39.
Germ cell tumors of the testes represent a unique paradigm of diseases which can be cured even in extremely advanced phase.
Unfortunately, this makes them unique among adult solid tumors. Seminoma and non seminoma are relatively rare with approximatively
25,000 patients in Europe per year, but numbers are increasing world wide. Different strategies are needed depending on stage
and prognostic scores. Seminoma is extremely sensitive to radiation therapy and chemotherapy, while all germ cell tumors show
a very good response to chemotherapy. Clinical stage I seminoma is currently treated with radiation, single course carboplatin
or surveillance policy. Clinical stage I non seminoma can also be approached with different strategies such as retroperitoneal
lymph node dissection, observation or one-two courses of standard chemotherapy. Stage II seminoma may be treated with either
radiation or chemotherapy, while for all advanced stages chemotherapy is mandatory. Since the mid-eighties PEB (Cisplatin,
Etoposide and Bleomycin) is the regimen of choice and no other schedule has proved superior in terms of efficacy. Surgery
on the residual disease is crucial to the whole strategy and should be performed or attempted in all cases. Consequently,
the correct treatment strategy for these tumors does not depend only on the ability of a single physician, but on a skilled
team specialized in this particular tumor. Second line therapies (VeIP, PEI, TIP) can cure 25%–40% of patients, but improved
strategies for resistant tumors are desperately needed. High-dose chemotherapy has shown very good results in some studies
while being less impressive in others. In any case, it should remain an option for relapsing patients and could be used in
some cases of upfront chemotherapy in patients with slow marker decline, but this should only be considered in referring centers. 相似文献
40.
目的探讨环氧合酶-2(COX-2)反义核酸对膀胱癌细胞恶性表型的抑制作用。方法采用脂质体介导方法,分别构建转染COX-2反义真核表达载体和空载体的膀胱癌细胞系5637-AS细胞和5637-P细胞,RT-PCR及W estern b lot分析转染细胞COX-2 mRNA及蛋白表达水平。MTT比色实验、Boyden侵袭小室法和裸鼠成瘤实验分别检测转染细胞体外增殖速度、体外侵袭力和体内成瘤性。结果RT-PCR结果显示,5637-AS细胞COX-2/磷酸甘油醛脱氢酶(GAPDH)mRNA比值(0.65)明显低于5637(0.92)和5637-P细胞(0.90);W estern b lot提示5637-AS细胞COX-2/β-actin比值(0.29)明显低于5637细胞(0.46)和5637-P细胞(0.44)。MTT比色实验显示5637-AS细胞较5637-P、5637细胞生长速度减慢,三者倍增时间分别为3.6 d、2.9 d和2.9 d。体外侵袭实验结果表明,5637-AS侵袭细胞数显著低于5637细胞及5637-P细胞(18.20±5.97比45.40±8.12,18.20±5.97比44.10±6.47,P<0.01)。裸鼠成瘤实验中,5637-P、5637细胞接种裸鼠后第5天肿瘤长出,而5637-AS细胞第7天肿瘤长出;30 d后5637-AS细胞接种组瘤体重量(392.15 mg±33.58 mg)明显小于5637细胞(738.26 mg±66.32 mg),和5637-P细胞接种组(698.53 mg±88.76 mg),P<0.01。结论膀胱癌细胞中COX-2过表达与细胞的恶性表型相关,反义技术抑制COX-2表达可以逆转膀胱癌细胞的恶性表型。 相似文献